SBI Securities’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$423 Hold
28
﹤0.01% 3095
2026
Q1
$537 Buy
28
+8
+40% +$174 ﹤0.01% 2873
2025
Q4
$440 Sell
20
-5
-20% -$90 ﹤0.01% 2913
2025
Q3
$304 Buy
25
+7
+39% +$95 ﹤0.01% 3181
2025
Q2
$336 Hold
18
﹤0.01% 3127
2025
Q1
$345 Sell
18
-1
-5% -$29 ﹤0.01% 3013
2024
Q4
$684 Buy
+19
New +$643 ﹤0.01% 2771

Other funds holding TNDM

SBI Securities's TNDM Position: Q2 2026 in Review

SBI Securities held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 28 shares worth $423. The position accounts for ﹤0.01% of the portfolio, ranked #3095.

SBI Securities first reported a position in TNDM in Q4 2024 and has held it in 7 quarters since. The position peaked at $684 in Q4 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • SBI Securities held 28 shares of Tandem Diabetes Care worth $423 as of Q2 2026.
  • SBI Securities left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3095 holding.
  • SBI Securities first reported a position in Tandem Diabetes Care in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Tandem Diabetes Care position peaked at $684 in Q4 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.